Introduction

MINI-REVIEW
Mycoplasma genitalium and
performed to find linkage between these microorganisms and cancer.
Cancer Associations
Several in vitro evidences have demonstrated the potential of Mycoplasma species to malignant transformation and chromosomal instability of long term Mycoplasma-infected cell cultures (Paton et al., 1965; MacPherson and Russell, 1966; Tsai et al., 1995; ShawHuey et al., 1999; Zhang et al., 1999; 2006a; 2006b) . Also some epidemiological studies, based on detection of Mycoplasma strains in cancer samples or evaluation of antibody status against these microorganisms in cancer patients, have been documented (Erturhan et al., 2013) . M. hyorhinis (Ji et al., 2002) , M. penetrans (Zhu et al., 2007; Yan et al., 2009) , M. hominis (Barykova et al., 2011) and M. salivarium (Baracaldo et al., 2012) are the most detected species from cancer patients. In contrast, there are a few studies which are suggestive the absence of any association between Mycoplasma and cancer (Ebbesen and Lind, 1969; Zhang et al., 1998; Chanudet et al., 2007) . To find association between M genitalium and cancer, there are some reports based on detection of Mycoplasma species DNA in cancer samples using PCR and universal primers which are capable to detect several Mycoplasma species genome, including M genitalium (Huang et al., 2001; Pehlivan et al., 2005; Jun et al., 2008) , but in comparison to other species, the numbers of studies that have targeted just M genitalium-detection in cancer patients also studies for understanding this microorganism's role in cancer development are few. Idahl et al. (2011) have perfumed two works. First, using ELISA, they evaluated the presence of anti-M genitalium antibody in ovarian cancer patients. Their results were suggestive the possibility of association between M genitalium and ovarian cancer (Idahl et al., 2011) , but in another study, they could not detect M genitalium DNA from ovarian cancer specimens by Real time PCR (Idahl et al., 2010) . Biernat-Sudolska and colleagues, to show an association between presence of urogenital mycoplasmas and Human Papiloma Virus (HPV) infections (as an infection which strongly associate with cervical carcinogenesis), assessed the presences of this microorganisms by PCR using specific primers in cervical smears of women diagnosed with abnormal cervical cytology of various grades. Their statistical analysis demonstrated that the risk of HPV infection while already infected with any of the four analyzed species of Mycoplasmataceae (Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium) increased two-fold. With concomitant of U urealyticum infection, the risk of HPV infection was 4.7-fold greater than in the absence U urealyticum infection. Their investigation also in women with cervical cancer group showed a significant increase in the detection rate of U urealyticum in comparison to women with normal cytology but they did not detect infections with the Mycoplasma species (M hominis, M genitalium) in women with cervical cancer, although such infections were observed in other groups (ASCUS: atypical squamous cells of undetermined significance; LSIL: lowgrade squamous epithelial lesions; HSIL: high grade squamous epithelial lesions, and control-normal cytology groups). Thus, they suggested that M hominis, M genitalium infections do not play any major role in cervical carcinoma development (Biernat-Sudolska et al., 2011) . At least there are two studies related to the M genitalium effects on apoptosis, in one of them, the data did not show any significant effect on apoptosis in M genitalium-infected 32D (a murine myeloid cell) cell line (Zhang and Lo, 2007) . In contrast, the other one indicated M genitalium can inhibit apoptosis in 32D cell line (Feng et al., 1999) . Overall, it seems, the well documented in vivo and in vitro study has performed by Namiki et al. (2009) which their data demonstrated that infection the BPH-1 (Benign prostatic hyperplasia) cell by M genitalium for 19 weeks, induces increasing migration/invasion, the acquisition of anchorage-independent growth, karyotypic entropy and formation of xenograft tumors in immunecompromised mice (Namiki et al., 2009) .
It is clear, the epidemiological evidences to definitive explanation of M genitalium potential to cancer development are not enough and its possible mechanisms also are unclear. One of the major reasons for little studies in this area might be fastidious nature of M genitalium to culture that limited direct detection and required researchers to develop other methods. Nucleic acid amplification-based methods have widely used for detection of M genitalium in urogenital specimens (de Barbeyrac et al., 1993; Jurstrand et al., 2005; Edberg et al., 2008; Ouzounova-Raykova et al., 2011; Twin et al., 2011) , so it seems, this techniques and ELISA which has used to show antibody status against M genitalium in patient sera (Baseman et al., 2004; Svenstrup et al., 2006) could be useful tools in epidemiological studies. Immunohistochemistry (IHC) has been used to detection of Mycoplasma species in clinical tissue samples (Adegboye et al., 1995; Moorkamp et al., 2010; Yang et al., 2010a; 2010b) but, this method has not developed for M genitalium, although polyclonal and monoclonal antibodies (as main tools for Immunohistochemistry and other immunoassays methods) against major antigens of M genitalium have been produced (Svenstrup et al., 2002; Burgos et al., 2006; Zarei et al., 2011) . In situ hybridization (Saglie et al., 1988; Heiskanen-Kosma et al., 1992; McCully and Brock, 1992; Kwon and Chae, 1999; Yanget al., 2010) also is another method which has used to detection of Mycoplasma spices, therefore this methods also could be develop to show the presence of M genitalium genome in cancer samples.
Conclusion
Understanding the role of infectious agents on cancer development might be useful for developing new approaches to cancer prevention. The role of M genitalium like other Mycoplasma species in cancer is still conjectural. To improve our understanding about the initial or co-factorial probable roles of this microorganism in cancer, more epidemiological studies based on M genitalium-detection in cancer patient in comparison to control groups also more in vitro and in vivo studies for understanding its mechanisms to malignant transformation should be sought. By considering the prevalence of M genitalium infections (Jones et al., 2009 ) also emerging the resistance strains (Bradshaw et al., 2008; Jensen et al., 2008) , M genitalium needs more attention in infectious agent cancer-causing research area. DOI:http://dx.doi.org/10.7314/APJCP.2013.14.6 
